Key result
Statins offer uncertain cardiovascular benefits for primary prevention in low-risk individuals.
Why the study?
Uncertainties remain regarding the benefits of statins, particularly in people at low risk of cardiovascular disease, highlighting the need for better data to support shared decision-making.
Do statins provide clear benefits for primary prevention in people at low risk of cardiovascular disease?
Do statins provide clear benefits for primary prevention in people at low risk of cardiovascular disease?
This paper highlights the ongoing uncertainties regarding statin use for primary prevention in low-risk individuals and emphasizes the importance of shared decision making.
Answers are grounded in this paper and cite their sources.
Uncertain benefits support cautious statin use and shared decisions in low-risk primary prevention; leaves open need for targeted trials.
Paula Byrne, John Cullinan, and Susan Smith explain the uncertainties about the benefits of statins, particularly in people at low risk of cardiovascular disease, and the need for better data to help shared decision making
No takes yet. Share an insight, caveat, or question.
Byrne et al. (2019) studied this question. Statins for primary prevention of cardiovascular disease have uncertain benefits, particularly in low-risk individuals, highlighting a need for better data to guide shared decision making.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: